126 related articles for article (PubMed ID: 24486077)
1. Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model.
Tollefson MK; Karnes RJ; Kwon ED; Lohse CM; Rangel LJ; Mynderse LA; Cheville JC; Sebo TJ
Mayo Clin Proc; 2014 Mar; 89(3):308-18. PubMed ID: 24486077
[TBL] [Abstract][Full Text] [Related]
2. Risk Stratification by Quantification of Perineural Cancer Invasion on Prostate Needle Core Biopsy: Should It Be Counted?
Teramoto Y; Wang Y; Miyamoto H
J Urol; 2023 Oct; 210(4):639-648. PubMed ID: 37433144
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of systematic immune-inflammation index combined with Ki-67 index on prognosis of prostate cancer patients after laparoscopic radical prostatectomy.
Wu R; Hu M; Zhang P
BMC Urol; 2023 Dec; 23(1):210. PubMed ID: 38114926
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of perineural invasion encircled completely vs. incompletely by prostate cancer on needle core biopsy.
Nwanze J; Teramoto Y; Wang Y; Miyamoto H
Hum Pathol; 2024 Jan; 143():71-74. PubMed ID: 38135063
[TBL] [Abstract][Full Text] [Related]
5. Cell-cycle risk score more accurately determines the risk for metastases and death in prostatectomy patients compared with clinical features alone.
Swanson GP; Lenz L; Stone S; Cohen T
Prostate; 2021 Mar; 81(4):261-267. PubMed ID: 33475174
[TBL] [Abstract][Full Text] [Related]
6. Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effect.
Magi-Galluzzi C; Maddala T; Falzarano SM; Cherbavaz DB; Zhang N; Knezevic D; Febbo PG; Lee M; Lawrence HJ; Klein EA
Oncotarget; 2016 Jun; 7(23):33855-65. PubMed ID: 27121323
[TBL] [Abstract][Full Text] [Related]
7. A combined index to classify prognostic comorbidity in candidates for radical prostatectomy.
Froehner M; Kellner AE; Koch R; Baretton GB; Hakenberg OW; Wirth MP
BMC Urol; 2014 Mar; 14():28. PubMed ID: 24678762
[TBL] [Abstract][Full Text] [Related]
8. Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome.
Berney DM; Beltran L; Fisher G; North BV; Greenberg D; Møller H; Soosay G; Scardino P; Cuzick J
Br J Cancer; 2016 May; 114(10):1078-83. PubMed ID: 27100731
[TBL] [Abstract][Full Text] [Related]
9. Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort.
Cuzick J; Stone S; Fisher G; Yang ZH; North BV; Berney DM; Beltran L; Greenberg D; Møller H; Reid JE; Gutin A; Lanchbury JS; Brawer M; Scardino P
Br J Cancer; 2015 Jul; 113(3):382-9. PubMed ID: 26103570
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of perineural cancer invasion detected in prostate cores: Involvement of spatially contiguous versus separate biopsy sites.
Teramoto Y; Numbere N; Miyamoto H
Pathol Int; 2023 Sep; 73(9):473-475. PubMed ID: 37493104
[No Abstract] [Full Text] [Related]
11. A Study of Ki-67 Immunostaining in Prostate Carcinomas and Its Correlation with Gleason's Score and Prognosis: An Experience at a Tertiary Centre in the Himalayan Foothills.
Jha N; Phulware RH; Kumar A; Singh A; Durgapal P; Chowdhury N; Mittal A; Kishore S
Indian J Surg Oncol; 2024 Jun; 15(2):341-348. PubMed ID: 38741642
[TBL] [Abstract][Full Text] [Related]
12. Predicting prostate cancer progression: protocol for a retrospective cohort study to identify prognostic factors for prostate cancer outcomes using routine primary care data.
Merriel SWD; May MT; Martin RM
BMJ Open; 2018 Jan; 8(1):e019409. PubMed ID: 29391368
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation gene-based models indicating independent poor outcome in prostate cancer.
Vasiljević N; Ahmad AS; Thorat MA; Fisher G; Berney DM; Møller H; Foster CS; Cuzick J; Lorincz AT
BMC Cancer; 2014 Sep; 14():655. PubMed ID: 25193387
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Histomorphometric Features of Prostate Cancer Predict Patients Who Biochemically Recur Following Prostatectomy.
Duenweg SR; Brehler M; Lowman AK; Bobholz SA; Kyereme F; Winiarz A; Nath B; Iczkowski KA; Jacobsohn KM; LaViolette PS
Lab Invest; 2023 Dec; 103(12):100269. PubMed ID: 37898290
[TBL] [Abstract][Full Text] [Related]
15. Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced Prostate Cancer.
Schwarz S; Nientiedt C; Prigge ES; Kaczorowski A; Geisler C; Lucena Porcel C; von Knebel Doeberitz M; Hohenfellner M; Duensing S
Pathobiology; 2023; 90(5):312-321. PubMed ID: 37004506
[TBL] [Abstract][Full Text] [Related]
16. Molecular Characterization of Prostate Cancer with Associated Gleason Score Using Mass Spectrometry Imaging.
Randall EC; Zadra G; Chetta P; Lopez BGC; Syamala S; Basu SS; Agar JN; Loda M; Tempany CM; Fennessy FM; Agar NYR
Mol Cancer Res; 2019 May; 17(5):1155-1165. PubMed ID: 30745465
[TBL] [Abstract][Full Text] [Related]
17. A Multi-scale U-Net for Semantic Segmentation of Histological Images from Radical Prostatectomies.
Li J; Sarma KV; Chung Ho K; Gertych A; Knudsen BS; Arnold CW
AMIA Annu Symp Proc; 2017; 2017():1140-1148. PubMed ID: 29854182
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of location of perineural cancer invasion detected on prostate needle core biopsy.
Gertsen BG; Teramoto Y; Wang Y; Tsuzuki T; Miyamoto H
Virchows Arch; 2024 Mar; ():. PubMed ID: 38485762
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer: Relationship between vascular diameter, shape and density and Gleason score in needle biopsy specimens.
Tadayyon F; Mellat M; Alizadeh F; Hadi M; Khorrami M; Yazdani M; Joozdani RH
Adv Biomed Res; 2013; 2():3. PubMed ID: 23930248
[TBL] [Abstract][Full Text] [Related]
20. Automated analysis of co-localized protein expression in histologic sections of prostate cancer.
Tennill TA; Gross ME; Frieboes HB
PLoS One; 2017; 12(5):e0178362. PubMed ID: 28552967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
